Jelen LA

Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, SE5 8AF, UK.

7 papers · 1 preprint · ORCID

ArticleKetamine

Modulation of GABA and glutamate by ketamine in depression: A systematic review and meta-analysis of magnetic resonance spectroscopy studies.

Singh B, Ali HM, Miola A +8

Europe PMC2026
ArticlePsilocybin

Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.

Rucker JJ, Mantingh T, Kerr-Gaffney J +26

Europe PMC2026
ArticleKetamine

Regional Blood Flow Signatures of Opioidergic Modulation of Ketamine in Major Depressive Disorder: A Randomized Crossover Study.

Jelen LA, O'Daly O, Zelaya FO +3

Europe PMC2026
ArticleKetamine

Methodological considerations for interpreting ketamine-naltrexone trials in depression.

Bandeira ID, Jelen LA, Tucciarone JM +3

Europe PMC2025
PreprintKetamine

Regional blood flow signatures of opioidergic modulation of ketamine in major depressive disorder: a randomised crossover study

Jelen LA, O’Daly O, Zelaya FO +3

Europe PMC2025
ArticleKetamine

Effect of naltrexone pretreatment on ketamine-induced glutamatergic activity and symptoms of depression: a randomized crossover study.

Jelen LA, Lythgoe DJ, Stone JM +2

Europe PMC2025
ArticleKetamine

Guidelines for ketamine use in clinical psychiatry practice.

Jelen LA, McShane R, Young AH

Europe PMC2024
ArticlePsilocybin

Psychedelics in the treatment of unipolar mood disorders: a systematic review.

Rucker JJ, Jelen LA, Flynn S +2

Europe PMC2016